Psoriasis Clinical Trials

• Age ≥ 18 or ≤75 years old at screening, regardless of gender;

• Meet the diagnostic criteria defined by the 2017 European Society for Clinical Nutrition and Metabolism (ESPEN) Research Workshop (ERASPEN) consensus and be diagnosed as （generalized pustular psoriasis(GPP);

• Compliant with GPP acute onset;

• Able to read and understand, and willing to sign the informed consent form;

• Willing and compliant with study visits and related procedures;

• Female subjects of childbearing age should agree that contraceptive measures must be used during the study and for 6 months after the end of the study;